ImmunosuppressantsCOVID-19 infection: 7 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2021年 / 1869卷 / 1期

关键词：

D O I：

10.1007/s40278-021-01047-2

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：182 / 182

相关论文

共 50 条

[41] ImmunosuppressantsCOVID-2019 infections: 7 case reports
Reactions Weekly, 2020, 1809 (1) : 133 - 134
[42] ImmunosuppressantsCOVID-2019: 23 case reports
Reactions Weekly, 2020, 1829 (1) : 212 - 212
[43] Adalimumab/ustekinumab/vedolizumabCOVID-19 infection: 7 case reports
Reactions Weekly, 2022, 1894 (1) : 22 - 22
[44] NatalizumabCOVID-19 infection: 19 case reports
Reactions Weekly, 2022, 1896 (1) : 355 - 355
[45] AntineoplasticsCOVID-19 infection: 19 case reports
Reactions Weekly, 2022, 1937 (1) : 55 - 55
[46] AntineoplasticsCovid-19 infection: 19 case reports
Reactions Weekly, 2021, 1853 (1) : 47 - 47
[47] AzathioprineEnterocytozoon bieneusi infection: 7 case reports
Reactions Weekly, 2022, 1905 (1) : 101 - 101
[48] Calcineurin-inhibitors/corticosteroids/mycophenolate-mofetilCOVID-19 infection: 7 case reports
Reactions Weekly, 2022, 1920 (1) : 126 - 126
[49] Antivirals/immunosuppressantsResistant cytomegalovirus infection: 7 case reports
Reactions Weekly, 2019, 1737 (1) : 47 - 47
[50] Adalimumab/etanerceptLatent tuberculosis infection: 7 case reports
Reactions Weekly, 2013, 1444 (1) : 6 - 6

← 1 2 3 4 5 →